Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 28, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 28, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 26, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 12, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 12, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 19, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 19, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 19, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 29, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 27, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 27, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 1, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 29, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 29, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 29, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 26, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 26, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 28, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 17, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 17, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 17, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 2, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 2, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 13, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 28, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 21, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 21, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 21, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 21, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 21, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 20, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 20, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 20, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 14, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 9, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Class 010
biopsy tests and devices, namely, medical instruments for use in performing tissue biopsies and medical diagnostic apparatus for testing changes in biomarkers; cancer screening tests and devices, namely, medical devices for post-cancer treatment reoccurrence monitoring; medical diagnostic apparatus for testing patients' post-cancer treatment biomarkers
Class 042
Providing reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
Classification
International Classes
001
005
010
042